After 30 years of use in transplant medicine, EBV-specific T cells offer key lessons for safer, scalable allogeneic cell therapies, writes Ivan Horak, M.D.

The most difficult biological-security problem today is not simply the existence of biological weapons. It is the speed at ...

What is optogenetics? The Nobel-winning technology uses light to control specific cells, helping scientists understand how ...

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized ...

Italian researchers used sequential statistical design to assemble synthetic microbial communities of acetic acid bacteria, ...

Andrew Huberman, the Stanford neuroscientist, predicts that the world's most powerful AI labs will inevitably pivot to biotech, driven by a ...

A new bibliometric review reveals that artificial intelligence and catalysis, despite explosive individual growth, intersect ...

Growing inside each of us is a cellular family tree. Every one of the 37 trillion cells in our body is generated from another ...

Genetically modified organisms could become the newest recruits in Minnesota’s long and largely losing battle against ...

Years ago, well before becoming a CEO, I was a vice president and the only woman on my business unit's senior leadership team ...